Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN110656148A details a novel biotransformation route for DHEA. This method offers substantial cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel rhodium-catalyzed route for ((1R,8S,9S,Z)-bicyclo[6.1.0]non-4-en-9-yl)methanol eliminates chromatography, offering scalable bioorthogonal chemistry solutions.
Patent CN102816825A reveals a novel microbial fermentation route for DHEA from plant sterols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN106701882A details a novel chemo-enzymatic route for UDCA production offering high purity and scalable manufacturing capabilities for global pharmaceutical supply chains.
Patent CN117430526B details a high-purity synthesis method for cefixime side chain impurities ensuring reliable quality control and supply chain stability for pharmaceutical intermediates.
Patent CN106478515B reveals a novel method for Azilsartan intermediate synthesis, offering high purity and simplified workup for reliable pharmaceutical supply chains.
Novel three-step synthesis of Chrysin improves yield and purity. Cost-effective manufacturing solution for pharmaceutical intermediates supply chain.
Patent CN101652350B reveals a cost-effective iodide-mediated dehalogenation route for high-purity 2-haloimidazoles, enhancing supply chain reliability.
Discover the novel synthesis route for Macitentan intermediates disclosed in CN107162988B. Achieve higher purity and reduced costs by eliminating late-stage ethylene glycol purification.
Novel Pd/C water-based method for indole-2-carboxylic acid. Reduces cost, improves safety, ensures high purity for pharmaceutical supply chains.
Novel t-BuOK promoted room temperature synthesis of N-dithiocarbamate indoles. High yield, simple operation, ideal for reliable pharmaceutical intermediate supplier.
Patent CN115745825B details nickel-catalyzed amide alkylation. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates supply chains.
Patent CN120136946B reveals a one-pot dienogest method reducing waste and cost. Enhances supply chain reliability for high-purity API manufacturing globally.
Patent CN104402803A details high-yield L-high proline synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability for global buyers.
Patent CN117603169B reveals a novel route for pilocarpine intermediates. Achieve higher yields and safer scale-up for pharmaceutical manufacturing supply chains.
Patent CN112300184B details a high-yield route for racemic camptothecin intermediates. Discover cost-effective manufacturing and supply chain advantages for API production.
Advanced catalytic method for high-purity 1-amino-2,3-propanediol synthesis. Reduces by-products and enhances supply chain reliability for iohexol intermediates.
Patent CN114230468A reveals a green SBA-15 catalytic route for nitrobenzaldehyde. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel nucleophilic substitution route for Montelukast intermediate. High optical purity, mild conditions, cost-effective manufacturing for global supply chains.
Patent CN104693071A reveals high-yield Vorinostat synthesis. Enables cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.